Literature DB >> 32612018

Impact of Renal Dysfunction on Left Atrial Structural Remodeling and Recurrence After Catheter Ablation for Atrial Fibrillation - A Propensity Score Matching Analysis.

Yuya Takahashi1,2, Takanori Yamaguchi1,2, Akira Fukui2,3, Toyokazu Otsubo1,2, Kei Hirota2,3, Yuki Kawano2, Kana Nakashima1, Mai Tahara1, Takayuki Kitai1, Atsushi Kawaguchi4, Naohiko Takahashi3, Koichi Node1.   

Abstract

BACKGROUND: Renal dysfunction coexists with other known risk factors of left atrial (LA) structural remodeling, expressed as low-voltage zones (LVZs), and the recurrence of atrial fibrillation (AF) after ablation. This study aimed to determine whether renal dysfunction had an independent effect on the presence of LVZs and recurrence after AF ablation, using propensity score (PS) matching analysis.Methods and 
Results: 448 consecutive patients who underwent their initial AF ablation were enrolled. Chronic kidney disease (CKD) was defined as an estimated glomerular filtration rate (eGFR) <60 mL/min/1.73 m2, with 126 (28%) patients having CKD. Using PS matching analysis, new subsets (CKD and non-CKD group, n=103 each) were obtained, matched for age, sex, AF type, and LA volume. The presence of LVZs defined as bipolar voltage <0.5 mV was higher in the CKD group than in the non-CKD group (31% vs. 17%, P=0.034). Multivariate analysis showed eGFR was an independent predictor of the presence of LVZs (odds ratio 1.31 per 10-mL/min/1.73 m2decrease, P=0.029). AF-free survival rate was significantly lower in the CKD patients during 20±9 months of follow-up (63% vs. 82%, P=0.019), and eGFR was shown to be an independent predictor of recurrence (hazard ratio 1.29 per 10-mL/min/1.73 m2decrease, P=0.006), but the presence of LVZs did not predict recurrence.
CONCLUSIONS: Renal dysfunction independently predicted not only the recurrence of AF after ablation but also the presence of LVZs.

Entities:  

Keywords:  Atrial fibrillation; Catheter ablation; Chronic kidney disease; Fibrosis; Low-voltage zone

Year:  2020        PMID: 32612018     DOI: 10.1253/circj.CJ-20-0149

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  4 in total

1.  The effect of concomitant chronic kidney disease on the recurrence of atrial fibrillation after catheter ablation: A protocol for systematic review and meta-analysis.

Authors:  Xiaodong Liu; Dapeng Wang; Bo Tang; Xiuying Lv
Journal:  Medicine (Baltimore)       Date:  2021-05-21       Impact factor: 1.817

2.  Pharmacological Cardioversion in Patients with Recent-Onset Atrial Fibrillation and Chronic Kidney Disease Subanalysis of the CANT II Study.

Authors:  Beata Ceynowa-Sielawko; Maciej T Wybraniec; Aleksandra Topp-Zielińska; Aleksander Maciąg; Dawid Miśkowiec; Paweł Balsam; Maciej Wójcik; Wojciech Wróbel; Michał M Farkowski; Edyta Ćwiek-Rębowska; Krzysztof Ozierański; Robert Błaszczyk; Karolina Bula; Tomasz Dembowski; Michał Peller; Bartosz Krzowski; Wojciech Wańha; Marek Koziński; Jarosław D Kasprzak; Hanna Szwed; Katarzyna Mizia-Stec; Marek Szołkiewicz
Journal:  Int J Environ Res Public Health       Date:  2022-04-17       Impact factor: 3.390

3.  DR-FLASH Score Is Useful for Identifying Patients With Persistent Atrial Fibrillation Who Require Extensive Catheter Ablation Procedures.

Authors:  Taiki Sato; Yohei Sotomi; Shungo Hikoso; Daisaku Nakatani; Hiroya Mizuno; Katsuki Okada; Tomoharu Dohi; Tetsuhisa Kitamura; Akihiro Sunaga; Hirota Kida; Bolrathanak Oeun; Yasuyuki Egami; Tetsuya Watanabe; Hitoshi Minamiguchi; Miwa Miyoshi; Nobuaki Tanaka; Takafumi Oka; Masato Okada; Takashi Kanda; Yasuhiro Matsuda; Masato Kawasaki; Masaharu Masuda; Koichi Inoue; Yasushi Sakata
Journal:  J Am Heart Assoc       Date:  2022-08-05       Impact factor: 6.106

4.  Improvement in Quality of Life via Catheter Ablation for Atrial Fibrillation in Patients Undergoing Hemodialysis Therapy.

Authors:  Masato Hachisuka; Hiroshi Hayashi; Yu-Ki Iwasaki; Nobuaki Ito; Toshiki Arai; Serina Kobayashi; Rei Mimuro; Yuhi Fujimoto; Eiichiro Oka; Kanako Hagiwara; Ippei Tsuboi; Hiroshige Murata; Teppei Yamamoto; Michio Ogano; Kenji Yodogawa; Meiso Hayashi; Wataru Shimizu
Journal:  CJC Open       Date:  2022-06-13
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.